Ziyi Chang1,2, Guizhen Zhao1, Yang Zhao1, Haocheng Lu1, Wenhao Xiong1, Wenying Liang1, Jinjian Sun1,3, Huilun Wang1, Tianqing Zhu1, Oren Rom1, Yanhong Guo1, Yanbo Fan1, Lin Chang1, Bo Yang4, Minerva T Garcia-Barrio1, Jiandie D Lin5, Y Eugene Chen1, Jifeng Zhang1. 1. Department of Internal Medicine, Frankel Cardiovascular Center (Z.C., G.Z., Y.Z., H.L., W.X., W.L., J.S., H.W., T.Z., O.R., Y.G., Y.F., L.C., M.T.G.-B., Y.E.C., J.Z.), University of Michigan Medical Center, Ann Arbor. 2. Department of Metabolism and Endocrinology (Z.C.), The Second Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China. 3. Department of Cardiovascular Medicine (J.S.), The Second Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China. 4. Department of Cardiac Surgery (B.Y.), University of Michigan Medical Center, Ann Arbor. 5. Life Sciences Institute and Department of Cell and Developmental Biology, University of Michigan, Ann Arbor (J.D.L.).
Abstract
OBJECTIVE: Currently, there are no approved drugs for abdominal aortic aneurysm (AAA) treatment, likely due to limited understanding of the primary molecular mechanisms underlying AAA development and progression. BAF60a-a unique subunit of the SWI/SNF (switch/sucrose nonfermentable) chromatin remodeling complex-is a novel regulator of metabolic homeostasis, yet little is known about its function in the vasculature and pathogenesis of AAA. In this study, we sought to investigate the role and underlying mechanisms of vascular smooth muscle cell (VSMC)-specific BAF60a in AAA formation. Approach and Results: BAF60a is upregulated in human and experimental murine AAA lesions. In vivo studies revealed that VSMC-specific knockout of BAF60a protected mice from both Ang II (angiotensin II)-induced and elastase-induced AAA formation with significant suppression of vascular inflammation, monocyte infiltration, and elastin fragmentation. Through RNA sequencing and pathway analysis, we found that the expression of inflammatory response genes in cultured human aortic smooth muscle cells was significantly downregulated by small interfering RNA-mediated BAF60a knockdown while upregulated upon adenovirus-mediated BAF60a overexpression. BAF60a regulates VSMC inflammation by recruiting BRG1 (Brahma-related gene-1)-a catalytic subunit of the SWI/SNF complex-to the promoter region of NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) target genes. Furthermore, loss of BAF60a in VSMCs prevented the upregulation of the proteolytic enzyme cysteine protease CTSS (cathepsin S), thus ameliorating ECM (extracellular matrix) degradation within the vascular wall in AAA. CONCLUSIONS: Our study demonstrated that BAF60a is required to recruit the SWI/SNF complex to facilitate the epigenetic regulation of VSMC inflammation, which may serve as a potential therapeutic target in preventing and treating AAA.
OBJECTIVE: Currently, there are no approved drugs for abdominal aortic aneurysm (AAA) treatment, likely due to limited understanding of the primary molecular mechanisms underlying AAA development and progression. BAF60a-a unique subunit of the SWI/SNF (switch/sucrose nonfermentable) chromatin remodeling complex-is a novel regulator of metabolic homeostasis, yet little is known about its function in the vasculature and pathogenesis of AAA. In this study, we sought to investigate the role and underlying mechanisms of vascular smooth muscle cell (VSMC)-specific BAF60a in AAA formation. Approach and Results: BAF60a is upregulated in human and experimental murine AAA lesions. In vivo studies revealed that VSMC-specific knockout of BAF60a protected mice from both Ang II (angiotensin II)-induced and elastase-induced AAA formation with significant suppression of vascular inflammation, monocyte infiltration, and elastin fragmentation. Through RNA sequencing and pathway analysis, we found that the expression of inflammatory response genes in cultured human aortic smooth muscle cells was significantly downregulated by small interfering RNA-mediated BAF60a knockdown while upregulated upon adenovirus-mediated BAF60a overexpression. BAF60a regulates VSMC inflammation by recruiting BRG1 (Brahma-related gene-1)-a catalytic subunit of the SWI/SNF complex-to the promoter region of NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) target genes. Furthermore, loss of BAF60a in VSMCs prevented the upregulation of the proteolytic enzyme cysteine protease CTSS (cathepsin S), thus ameliorating ECM (extracellular matrix) degradation within the vascular wall in AAA. CONCLUSIONS: Our study demonstrated that BAF60a is required to recruit the SWI/SNF complex to facilitate the epigenetic regulation of VSMC inflammation, which may serve as a potential therapeutic target in preventing and treating AAA.
Authors: F L Moll; J T Powell; G Fraedrich; F Verzini; S Haulon; M Waltham; J A van Herwaarden; P J E Holt; J W van Keulen; B Rantner; F J V Schlösser; F Setacci; J-B Ricco Journal: Eur J Vasc Endovasc Surg Date: 2011-01 Impact factor: 7.069
Authors: K Cartharius; K Frech; K Grote; B Klocke; M Haltmeier; A Klingenhoff; M Frisch; M Bayerlein; T Werner Journal: Bioinformatics Date: 2005-04-28 Impact factor: 6.937
Authors: Vladimir R Ramirez-Carrozzi; Aaron A Nazarian; Caiyi C Li; Sarah L Gore; Rupa Sridharan; Anthony N Imbalzano; Stephen T Smale Journal: Genes Dev Date: 2006-02-01 Impact factor: 11.361
Authors: Hisashi Sawada (澤田悠); Hong S Lu (吕红); Lisa A Cassis; Alan Daugherty Journal: Arterioscler Thromb Vasc Biol Date: 2022-01-20 Impact factor: 8.311
Authors: Haocheng Lu; Wa Du; Lu Ren; Milton H Hamblin; Richard C Becker; Y Eugene Chen; Yanbo Fan Journal: J Am Heart Assoc Date: 2021-11-19 Impact factor: 6.106